FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Test, Tumor Marker, For Detection Of Bladder Cancer

PMA: P940035 · Supplement: S006 · Decision Nov 15, 2011
Classifications
1
FEI Numbers
4
Registration Numbers
4

Basic Information

Device Name
System, Test, Tumor Marker, For Detection Of Bladder Cancer
Trade Name
NMP22 BLADDERCHEK TEST KIT
PMA Number
P940035
Supplement Number
S006
Device Class
FDA Class 3
Product Code
NAH
Generic Name
System, test, tumor marker, for detection of bladder cancer
Medical Specialty
Unknown
Advisory Committee
Immunology
Decision
Approved
Decision Code
APPR
Decision Date
November 15, 2011
Date Received
May 11, 2011
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR MANUFACTURING SITE LOCATED AT ALERE SCARBOROUGH, INC. IN SCARBOROUGH, MAINE.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NAH System, Test, Tumor Marker, For Detection Of Bladder Cancer